Full suite of drug development services for your Small Molecules
Eurofins CDMO provides integrated, end-to-end drug development solutions supporting clients from the earliest phases of API research and development through finished products.
We offer a full suite of drug development services encompassing preclinical development, formulation screening and development, and analytical development, as well as sterile and non-sterile manufacturing of clinical trial batches, small commercial batches and orphan drugs. We also work with clients and CMOs to provide seamless process transfer for large scale commercial manufacturing.
With more than two decades of development and manufacturing experience and 13 state-of-the-art facilities worldwide, Eurofins CDMO provides high-quality, customized solutions for complex products and unique production processes, specializing in the development of innovative formulation technologies and solutions to enhance bioavailability and control drug release for difficult-to-formulate drug candidates.
Our expertise for your Drug Product
Choose the Eurofins CDMO network of companies to help you:
- Accelerate pre-clinical and clinical phases of your product with easy scale-up and smooth transfer from development to GMP facilities, including fill & finish suites (manufacturing under isolator and single-use material).
- Perform complex formulation screening and development with a vast array of innovative technologies.
- Enhance bioavailability of poorly soluble drugs and controlling drug release.
- Develop and validate stability indicating methods, as well as stability evaluation of drug substances and developed drug products, including Accelerated Stability, ICH Stability, In-Use Stability, and Accelerated Stability Assessment Programs (ASAPs).
- Perform clinical trial manufacturing of non-sterile and sterile drug products.
- Perform commercial manufacturing (small commercial batches) and Orphan drugs.
- Ensure regulatory support throughout the complete development pathway.
To learn more